vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and SIFCO INDUSTRIES INC (SIF). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $24.0M, roughly 2.0× SIFCO INDUSTRIES INC). SIFCO INDUSTRIES INC runs the higher net margin — 7.5% vs -4.8%, a 12.2% gap on every dollar of revenue. On growth, SIFCO INDUSTRIES INC posted the faster year-over-year revenue change (14.8% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $8.0M). Over the past eight quarters, SIFCO INDUSTRIES INC's revenue compounded faster (8.1% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
SIFCO Industries, Inc. (SIFCO), is a global metal component manufacturer based in Cleveland, Ohio.
IRWD vs SIF — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $47.7M | $24.0M |
| Net Profit | $-2.3M | $1.8M |
| Gross Margin | — | 21.6% |
| Operating Margin | 14.3% | 10.7% |
| Net Margin | -4.8% | 7.5% |
| Revenue YoY | -47.3% | 14.8% |
| Net Profit YoY | -200.9% | 177.3% |
| EPS (diluted) | $0.01 | $0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | $24.0M | ||
| Q3 25 | $122.1M | $22.8M | ||
| Q2 25 | $85.2M | $22.1M | ||
| Q1 25 | $41.1M | $19.0M | ||
| Q4 24 | $90.5M | $20.9M | ||
| Q3 24 | $91.6M | $21.7M | ||
| Q2 24 | $94.4M | $22.0M | ||
| Q1 24 | $74.9M | $20.5M |
| Q4 25 | $-2.3M | $1.8M | ||
| Q3 25 | $40.1M | $-429.0K | ||
| Q2 25 | $23.6M | $3.4M | ||
| Q1 25 | $-37.4M | $-1.4M | ||
| Q4 24 | $2.3M | $-2.3M | ||
| Q3 24 | $3.6M | $-443.0K | ||
| Q2 24 | $-860.0K | $72.0K | ||
| Q1 24 | $-4.2M | $-1.6M |
| Q4 25 | — | 21.6% | ||
| Q3 25 | — | 9.6% | ||
| Q2 25 | — | 26.7% | ||
| Q1 25 | — | 8.3% | ||
| Q4 24 | — | 4.4% | ||
| Q3 24 | — | 10.7% | ||
| Q2 24 | — | 12.3% | ||
| Q1 24 | — | 7.3% |
| Q4 25 | 14.3% | 10.7% | ||
| Q3 25 | 61.8% | -1.7% | ||
| Q2 25 | 53.2% | 14.8% | ||
| Q1 25 | -70.7% | -4.1% | ||
| Q4 24 | 34.8% | -9.2% | ||
| Q3 24 | 28.0% | -1.5% | ||
| Q2 24 | 26.5% | 0.7% | ||
| Q1 24 | 14.7% | -6.5% |
| Q4 25 | -4.8% | 7.5% | ||
| Q3 25 | 32.8% | -1.9% | ||
| Q2 25 | 27.7% | 15.4% | ||
| Q1 25 | -90.9% | -7.3% | ||
| Q4 24 | 2.5% | -11.1% | ||
| Q3 24 | 4.0% | -2.0% | ||
| Q2 24 | -0.9% | 0.3% | ||
| Q1 24 | -5.6% | -7.8% |
| Q4 25 | $0.01 | $0.29 | ||
| Q3 25 | $0.23 | $-0.07 | ||
| Q2 25 | $0.14 | $0.56 | ||
| Q1 25 | $-0.23 | $-0.23 | ||
| Q4 24 | $0.03 | $-0.38 | ||
| Q3 24 | $0.02 | $-0.07 | ||
| Q2 24 | $-0.01 | $0.01 | ||
| Q1 24 | $-0.03 | $-0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | $1.1M |
| Total DebtLower is stronger | — | $39.0K |
| Stockholders' EquityBook value | $-261.8M | $38.7M |
| Total Assets | $396.9M | $74.9M |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | $1.1M | ||
| Q3 25 | $140.4M | $491.0K | ||
| Q2 25 | $92.9M | $2.0M | ||
| Q1 25 | $108.5M | $1.9M | ||
| Q4 24 | $88.6M | $3.1M | ||
| Q3 24 | $88.2M | $1.7M | ||
| Q2 24 | $105.5M | $3.4M | ||
| Q1 24 | $121.5M | $2.5M |
| Q4 25 | — | $39.0K | ||
| Q3 25 | $199.5M | $51.0K | ||
| Q2 25 | $199.3M | — | ||
| Q1 25 | $199.2M | — | ||
| Q4 24 | $199.0M | — | ||
| Q3 24 | $198.8M | $0 | ||
| Q2 24 | $198.6M | $3.6M | ||
| Q1 24 | $398.3M | $4.1M |
| Q4 25 | $-261.8M | $38.7M | ||
| Q3 25 | $-264.2M | $36.9M | ||
| Q2 25 | $-308.2M | $35.8M | ||
| Q1 25 | $-334.1M | $32.4M | ||
| Q4 24 | $-301.3M | $33.7M | ||
| Q3 24 | $-311.3M | $30.4M | ||
| Q2 24 | $-321.7M | $29.8M | ||
| Q1 24 | $-330.5M | $29.7M |
| Q4 25 | $396.9M | $74.9M | ||
| Q3 25 | $396.1M | $73.4M | ||
| Q2 25 | $342.9M | $77.3M | ||
| Q1 25 | $327.2M | $78.8M | ||
| Q4 24 | $350.9M | $81.0M | ||
| Q3 24 | $389.5M | $104.6M | ||
| Q2 24 | $395.6M | $106.3M | ||
| Q1 24 | $438.8M | $104.2M |
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 0.14× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $8.1M |
| Free Cash FlowOCF − Capex | $74.6M | $8.0M |
| FCF MarginFCF / Revenue | 156.3% | 33.3% |
| Capex IntensityCapex / Revenue | 0.0% | 0.4% |
| Cash ConversionOCF / Net Profit | — | 4.51× |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | $11.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $8.1M | ||
| Q3 25 | $47.6M | $726.0K | ||
| Q2 25 | $-15.1M | $371.0K | ||
| Q1 25 | $20.0M | $2.8M | ||
| Q4 24 | $15.2M | $-3.8M | ||
| Q3 24 | $9.9M | $857.0K | ||
| Q2 24 | $33.5M | $382.0K | ||
| Q1 24 | $45.0M | $-3.2M |
| Q4 25 | $74.6M | $8.0M | ||
| Q3 25 | $47.6M | $566.0K | ||
| Q2 25 | $-15.1M | $310.0K | ||
| Q1 25 | $19.9M | $2.7M | ||
| Q4 24 | — | $-3.9M | ||
| Q3 24 | $9.9M | $580.0K | ||
| Q2 24 | $33.4M | $-175.0K | ||
| Q1 24 | $44.9M | $-3.9M |
| Q4 25 | 156.3% | 33.3% | ||
| Q3 25 | 39.0% | 2.5% | ||
| Q2 25 | -17.7% | 1.4% | ||
| Q1 25 | 48.4% | 14.1% | ||
| Q4 24 | — | -18.8% | ||
| Q3 24 | 10.8% | 2.7% | ||
| Q2 24 | 35.4% | -0.8% | ||
| Q1 24 | 60.0% | -18.9% |
| Q4 25 | 0.0% | 0.4% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | 0.0% | 0.3% | ||
| Q1 25 | 0.1% | 0.8% | ||
| Q4 24 | 0.0% | 0.5% | ||
| Q3 24 | 0.0% | 1.3% | ||
| Q2 24 | 0.1% | 2.5% | ||
| Q1 24 | 0.1% | 3.3% |
| Q4 25 | — | 4.51× | ||
| Q3 25 | 1.19× | — | ||
| Q2 25 | -0.64× | 0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.74× | — | ||
| Q3 24 | 2.71× | — | ||
| Q2 24 | — | 5.31× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRWD
Segment breakdown not available.
SIF
| Fixed Wing Aircraft Revenue | $10.5M | 44% |
| Commercial Revenue | $8.7M | 36% |
| Commercial Product And Other Revenue | $2.8M | 12% |
| Commercial Space | $1.1M | 5% |
| Other | $840.0K | 4% |